These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 33535238)

  • 1. Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Rehabilitation Facility: Evolution of the Presence of Nasopharyngeal SARS-CoV-2 and Serological Antibody Responses.
    Harris BHL; Zuhair M; Di Giovannantonio M; Rosadas C; Khan M; Short CE; Thaventhiran T; Quinlan R; Taylor A; Calvez R; Taylor GP; Tedder RS; McClure MO; Fertleman M
    J Infect Dis; 2021 Feb; 223(2):192-196. PubMed ID: 33535238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study.
    Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW;
    Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal screening in gravids during labor and delivery.
    Savirón-Cornudella R; Villalba A; Zapardiel J; Andeyro-Garcia M; Esteban LM; Pérez-López FR
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():400-404. PubMed ID: 33285496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
    Shragai T; Smith-Jeffcoat SE; Koh M; Schechter MC; Rebolledo PA; Kasinathan V; Wang Y; Hoffman A; Miller H; Tejada-Strop A; Jain S; Tamin A; Harcourt JL; Thornburg NJ; Wong P; Medrzycki M; Folster JM; Semenova V; Steward-Clark E; Drobenuic J; Biedron C; Stewart RJ; da Silva J; Kirking HL; Tate JE;
    J Infect Dis; 2022 Jan; 225(2):229-237. PubMed ID: 34216468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects.
    Huynh A; Arnold DM; Smith JW; Moore JC; Zhang A; Chagla Z; Harvey BJ; Stacey HD; Ang JC; Clare R; Ivetic N; Chetty VT; Bowdish DME; Miller MS; Kelton JG; Nazy I
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33923828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of SARS-CoV-2 nasopharyngeal swab PCR positivity in COVID-19 convalescent plasma donors.
    Ikegami S; Benirschke R; Flanagan T; Tanna N; Klein T; Elue R; Debosz P; Mallek J; Wright G; Guariglia P; Kang J; Gniadek TJ
    Transfusion; 2020 Dec; 60(12):2962-2968. PubMed ID: 32840002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA Load Status and Antibody Distribution Among Patients and Asymptomatic Carriers in Central China.
    Yuan Y; Wang H; Zhao J; Jing N; Xu J; Li W; Ma B; Zhang J; Li G; Wang S; Li Y; Wang Y; Fan E; Li L
    Front Cell Infect Microbiol; 2021; 11():559447. PubMed ID: 33816325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of SARS-CoV-2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
    Meyers KJ; Dillman B; Williams C; Jiang J; Clifford N; Miller JL; Jones ME; Goetz IA; Botros FT; Knorr J; Manner DH; Woodward B
    J Med Virol; 2021 May; 93(5):2925-2931. PubMed ID: 33463731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
    J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.
    To KK; Tsang OT; Leung WS; Tam AR; Wu TC; Lung DC; Yip CC; Cai JP; Chan JM; Chik TS; Lau DP; Choi CY; Chen LL; Chan WM; Chan KH; Ip JD; Ng AC; Poon RW; Luo CT; Cheng VC; Chan JF; Hung IF; Chen Z; Chen H; Yuen KY
    Lancet Infect Dis; 2020 May; 20(5):565-574. PubMed ID: 32213337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of SARS-CoV-2 N-Antibody Response in Healthcare Workers, London, UK.
    Shrotri M; Harris RJ; Rodger A; Planche T; Sanderson F; Mahungu T; McGregor A; Heath PT; ; Brown CS; Dunning J; Hopkins S; Ladhani S; Chand M
    Emerg Infect Dis; 2021 Apr; 27(4):1155-1158. PubMed ID: 33734962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Maternal and Neonatal SARS-CoV-2 Viral Load, Transplacental Antibody Transfer, and Placental Pathology in Pregnancies During the COVID-19 Pandemic.
    Edlow AG; Li JZ; Collier AY; Atyeo C; James KE; Boatin AA; Gray KJ; Bordt EA; Shook LL; Yonker LM; Fasano A; Diouf K; Croul N; Devane S; Yockey LJ; Lima R; Shui J; Matute JD; Lerou PH; Akinwunmi BO; Schmidt A; Feldman J; Hauser BM; Caradonna TM; De la Flor D; D'Avino P; Regan J; Corry H; Coxen K; Fajnzylber J; Pepin D; Seaman MS; Barouch DH; Walker BD; Yu XG; Kaimal AJ; Roberts DJ; Alter G
    JAMA Netw Open; 2020 Dec; 3(12):e2030455. PubMed ID: 33351086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No secret hiding place? Absence of SARS-CoV-2 on the ocular surface of 1145 hospitalized patients in a pandemic area.
    Rokohl AC; Grajewski RS; Wawer Matos PA; Koch HL; Dewald F; Klein F; Fätkenheuer G; Lehmann C; Cursiefen C; Heindl LM
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1605-1608. PubMed ID: 33511435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants.
    Morinaga Y; Tani H; Terasaki Y; Nomura S; Kawasuji H; Shimada T; Igarashi E; Saga Y; Yoshida Y; Yasukochi R; Kaneda M; Murai Y; Ueno A; Miyajima Y; Fukui Y; Nagaoka K; Ono C; Matsuura Y; Fujimura T; Ishida Y; Oishi K; Yamamoto Y
    Microbiol Spectr; 2021 Dec; 9(3):e0056021. PubMed ID: 34851163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave.
    Candoni A; Petruzzellis G; Sperotto A; Andreotti V; Giavarra M; Corvaja C; Minisini A; Comuzzi C; Tascini C; Fanin R; Fasola G
    PLoS One; 2022; 17(2):e0262784. PubMed ID: 35108300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 screening of asymptomatic women admitted for delivery must be performed with a combination of microbiological techniques: an observational study.
    Viñuela MC; De León-Luis JA; Alonso R; Catalán P; Lizarraga S; Muñoz P; Bouza E;
    Rev Esp Quimioter; 2020 Dec; 33(6):415-421. PubMed ID: 32945157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection.
    Clarke CL; Prendecki M; Dhutia A; Gan J; Edwards C; Prout V; Lightstone L; Parker E; Marchesin F; Griffith M; Charif R; Pickard G; Cox A; McClure M; Tedder R; Randell P; Greathead L; Guckian M; McAdoo SP; Kelleher P; Willicombe M
    Kidney Int; 2021 Jun; 99(6):1470-1477. PubMed ID: 33774082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study.
    Brotons P; Jordan I; Bassat Q; Henares D; Fernandez de Sevilla M; Ajanovic S; Redin A; Fumado V; Baro B; Claverol J; Varo R; Cuadras D; Hecht J; Barrabeig I; Garcia-Garcia JJ; Launes C; Muñoz-Almagro C
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.